CFR section
21 CFR 530.11(d): Limitations
PART 530-EXTRALABEL DRUG USE IN ANIMALS · Subpart B-Rules and Provisions for Extralabel Uses of Drugs in Animals
Key facts
| Citation | 21 CFR 530.11(d) |
|---|---|
| Section | Limitations |
| Part | PART 530-EXTRALABEL DRUG USE IN ANIMALS |
| Subpart | Subpart B-Rules and Provisions for Extralabel Uses of Drugs in Animals |
| Subchapter | 21 CFR E Drugs Animal |
| Product types cited | Drugs, Veterinary |
| Regulation text (excerpt) | (d) Extralabel use resulting in any residue above an established safe level, safe concentration or tolerance. |
At a glance
- 1,000+ Inspections citing this section
- 100–999 Warning letters citing this section
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About CFR sections cited by the FDA
Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.